Pan-cancer molecular patterns and biological implications associated with a tumor-specific molecular signature
Studying tissue-independent components of cancer and defining pan-cancer subtypes could be addressed using tissue-specific molecular signatures if classification errors are controlled. Since PAM50 is a well-known, United States Food and Drug Administration (FDA)-approved and commercially available b...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | Español |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | http://pa.bibdigital.ucc.edu.ar/3389/1/A_Rocha_Garcia_Montoro.pdf |
Aporte de: |
id |
I38-R144-3389 |
---|---|
record_format |
dspace |
institution |
Universidad Católica de Córdoba |
institution_str |
I-38 |
repository_str |
R-144 |
collection |
Producción Académica Universidad Católica de Córdoba (UCCor) |
language |
Español |
orig_language_str_mv |
spa |
topic |
R Medicina (General) RC0254 Neoplasias. Los tumores. Oncología (incluyendo cáncer) |
spellingShingle |
R Medicina (General) RC0254 Neoplasias. Los tumores. Oncología (incluyendo cáncer) Rocha, Darío García, Iris A. Montoro, Aldana González Llera, Andrea Sabina Prato, Laura Girotti, María Romina Soria, Gastón Fernández, Elmer Andrés Pan-cancer molecular patterns and biological implications associated with a tumor-specific molecular signature |
topic_facet |
R Medicina (General) RC0254 Neoplasias. Los tumores. Oncología (incluyendo cáncer) |
description |
Studying tissue-independent components of cancer and defining pan-cancer subtypes could be addressed using tissue-specific molecular signatures if classification errors are controlled. Since PAM50 is a well-known, United States Food and Drug Administration (FDA)-approved and commercially available breast cancer signature, we applied it with uncertainty assessment to classify tumor samples from over 33 cancer types, discarded unassigned samples, and studied the emerging tumor-agnostic molecular patterns. The percentage of unassigned samples ranged between 55.5% and 86.9% in non-breast tissues, and gene set analysis suggested that the remaining samples could be grouped into two classes (named C1 and C2) regardless of the tissue. The C2 class was more dedifferentiated, more proliferative, with higher centrosome amplification, and potentially more TP53 and RB1 mutations. We identified 28 gene sets and 95 genes mainly associated with cell-cycle progression, cell-cycle checkpoints, and DNA damage that were consistently exacerbated in the C2 class. In some cancer types, the C1/C2 classification was associated with survival and drug sensitivity, and modulated the prognostic meaning of the immune infiltrate. Our results suggest that PAM50 could be repurposed for a pan-cancer context when paired with uncertainty assessment, resulting in two classes with molecular, biological, and clinical implications. |
format |
Artículo Artículo |
author |
Rocha, Darío García, Iris A. Montoro, Aldana González Llera, Andrea Sabina Prato, Laura Girotti, María Romina Soria, Gastón Fernández, Elmer Andrés |
author_facet |
Rocha, Darío García, Iris A. Montoro, Aldana González Llera, Andrea Sabina Prato, Laura Girotti, María Romina Soria, Gastón Fernández, Elmer Andrés |
author_sort |
Rocha, Darío |
title |
Pan-cancer molecular patterns and biological implications associated with a tumor-specific molecular signature |
title_short |
Pan-cancer molecular patterns and biological implications associated with a tumor-specific molecular signature |
title_full |
Pan-cancer molecular patterns and biological implications associated with a tumor-specific molecular signature |
title_fullStr |
Pan-cancer molecular patterns and biological implications associated with a tumor-specific molecular signature |
title_full_unstemmed |
Pan-cancer molecular patterns and biological implications associated with a tumor-specific molecular signature |
title_sort |
pan-cancer molecular patterns and biological implications associated with a tumor-specific molecular signature |
publisher |
MDPI |
publishDate |
2020 |
url |
http://pa.bibdigital.ucc.edu.ar/3389/1/A_Rocha_Garcia_Montoro.pdf |
work_keys_str_mv |
AT rochadario pancancermolecularpatternsandbiologicalimplicationsassociatedwithatumorspecificmolecularsignature AT garciairisa pancancermolecularpatternsandbiologicalimplicationsassociatedwithatumorspecificmolecularsignature AT montoroaldanagonzalez pancancermolecularpatternsandbiologicalimplicationsassociatedwithatumorspecificmolecularsignature AT lleraandreasabina pancancermolecularpatternsandbiologicalimplicationsassociatedwithatumorspecificmolecularsignature AT pratolaura pancancermolecularpatternsandbiologicalimplicationsassociatedwithatumorspecificmolecularsignature AT girottimariaromina pancancermolecularpatternsandbiologicalimplicationsassociatedwithatumorspecificmolecularsignature AT soriagaston pancancermolecularpatternsandbiologicalimplicationsassociatedwithatumorspecificmolecularsignature AT fernandezelmerandres pancancermolecularpatternsandbiologicalimplicationsassociatedwithatumorspecificmolecularsignature |
bdutipo_str |
Repositorios |
_version_ |
1764820535871537154 |